CAP, IASLC, AMP Update Guideline for Molecular Testing and Targeted Therapies in Lung Cancer

February 2, 2018 – To ensure that clinicians stay apace and provide optimal patient care, three leading medical societies – the College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) – have updated their 2013 evidence-based guideline on molecular testing and targeted therapies in lung cancer. The Updated Molecular Testing Guideline for the Selection of Lung … (leggi tutto)